EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Different solubilizing ability of cyclodextrin derivatives for cholesterol in Niemann–Pick disease type C treatment

Yusei Yamada iD, Madoka Fukaura-Nishizawa, Asami Nishiyama, Akira Ishii, Tatsuya Kawata, Aina Shirakawa, Mayuko Tanaka, Yuki Kondo, Toru Takeo, Naomi Nakagata, Toru Miwa, Hiroki Takeda und 14 weitere

Clinical and Translational Medicine · 2023

DOI: 10.1002/ctm2.1350 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Medicine, 2023. Verfasst von Yusei Yamada und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Chemistry and Informatics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan. Hauptthemen laut MEDLINE: Cyclodextrins, Niemann-Pick Disease, Type C, Ototoxicity. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Niemann–Pick disease type C (NPC) is a fatal neurodegenerative disorder caused by abnormal intracellular cholesterol trafficking. Cyclodextrins (CDs), the most promising therapeutic candidates for NPC, but with concerns about ototoxicity, are cyclic oligosaccharides with dual functions of unesterified cholesterol (UC) shuttle and sink that catalytically enhance the bidirectional flux and net efflux of UC, respectively, between the cell membrane and the extracellular acceptors. However, the properties of CDs that regulate these functions and how they could be used to improve treatments for NPC are unclear.

Methods

We estimated CD–UC complexation for nine CD derivatives derived from native α‐, β‐, and γ‐CD with different cavity sizes, using solubility and molecular docking analyses. The stoichiometry and complexation ability of the resulting complexes were investigated in relation to the therapeutic effectiveness and toxicity of each CD derivative in NPC experimental models.

Findings

We found that shuttle and sink activities of CDs are dependent on cavity size‐dependent stoichiometry and substituent‐associated stability of CD–UC complexation. The ability of CD derivatives to form 1:1 and 2:1 complexes with UC were correlated with their ability to normalize intracellular cholesterol trafficking serving as shuttle and with their cytotoxicity associated with cellular UC efflux acting as sink, respectively, in NPC model cells. Notably, the ability of CD derivatives to form an inclusion complex with UC was responsible for not only efficacy but ototoxicity, while a representative derivative without this ability negligibly affected auditory function, underscoring its preventability.

Conclusions

Our findings highlight the importance of strategies for optimizing the molecular structure of CDs to overcome this functional dilemma in the treatment of NPC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CyclodextrinsNiemann-Pick Disease, Type COtotoxicityHumansMolecular Docking SimulationCholesterol

Stichwörter der Autor:innen

Niemann-pick disease type Ccholesterolcyclodextrinstoichiometry

Substanzen

CyclodextrinsCholesterol

Autor:innen und Institutionen

  • Department of Clinical Chemistry and Informatics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.
  • Department of Pharmacy, University of Miyazaki Hospital, Miyazaki, Japan.
  • Division of Reproductive Engineering, Center for Animal Resources and Development (CARD), Kumamoto University, Kumamoto, Japan.
  • Division of Reproductive Biotechnology and Innovation, Center for Animal Resources and Development (CARD), Kumamoto University, Kumamoto, Japan.
  • Department of Otolaryngology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
  • Department of Otolaryngology-Head and Neck Surgery, Graduate School of Medicine, Kumamoto University, Kumamoto, Japan.

ORCID-Profile: Yusei Yamada

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Yamada, Y., Fukaura-Nishizawa, M., Nishiyama, A., Ishii, A., Kawata, T., Shirakawa, A., Tanaka, M., Kondo, Y., Takeo, T., Nakagata, N., Miwa, T., Takeda, H., Orita, Y., Motoyama, K., Higashi, T., Arima, H., Seki, T., Kurauchi, Y., Katsuki, H., …, & Ishitsuka, Y. (2023). Different solubilizing ability of cyclodextrin derivatives for cholesterol in Niemann–Pick disease type C treatment. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.1350

Vancouver

Yamada Y, Fukaura-Nishizawa M, Nishiyama A, Ishii A, Kawata T, Shirakawa A, et al. Different solubilizing ability of cyclodextrin derivatives for cholesterol in Niemann–Pick disease type C treatment. Clinical and Translational Medicine. 2023. doi:10.1002/ctm2.1350

BibTeX
@article{Yamada2023,
  author = {Yamada, Yusei and Fukaura-Nishizawa, Madoka and Nishiyama, Asami and Ishii, Akira and Kawata, Tatsuya and Shirakawa, Aina and Tanaka, Mayuko and Kondo, Yuki and Takeo, Toru and Nakagata, Naomi and Miwa, Toru and Takeda, Hiroki and Orita, Yorihisa and Motoyama, Keiichi and Higashi, Taishi and Arima, Hidetoshi and Seki, Takahiro and Kurauchi, Yuki and Katsuki, Hiroshi and Higaki, Katsumi and Minami, Kentaro and Yoshikawa, Naoki and Ikeda, Ryuji and Matsuo, Muneaki and Irie, Tetsumi and Ishitsuka, Yoichi},
  title = {Different solubilizing ability of cyclodextrin derivatives for cholesterol in Niemann–Pick disease type C treatment},
  journal = {Clinical and Translational Medicine},
  year = {2023},
  doi = {10.1002/ctm2.1350}
}
Kostenlos starten →